# Boswellia Knee Pain Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/boswellia-knee-pain-randomized-trial-evidence-review
Category: evidence-review
Summary: Boswellia Knee Pain Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sy
Last reviewed: 2026-07-24
Reviewed by: Migaku Evidence Review
# Boswellia Knee Pain Randomized Trial: What the Evidence Says

## Quick Answer

Boswellia Knee Pain Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis | systematic review | 1 | 2025-08-03 | 10.3390/nu17152547 |
| Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion | preclinical study | 4 | 2026-05-21 | 10.7759/cureus.109411 |

## What The Sources Report

- However, prolonged NSAID use is associated with various adverse effects, including gastrointestinal complications, cardiovascular disease, and potential renal and hepatic toxicity. [Zhang Yuntong (2025); evidence level 1]
- As a result, many patients with KOA seek alternative or non-pharmacological therapies to relieve pain and functional impairment. [Zhang Yuntong (2025); evidence level 1]
- It causes chronic pain, reduced mobility, and disability, affecting 607 million individuals worldwide, with nearly 46.6 million new cases annually. [Muacevic Alexander (2026); evidence level 4]
- HLA-DRB1 HLA-DQB1 Genetic polymorphisms in sterol regulatory element-binding protein 2 (rs2228314), interleukin-6 (rs1800795), and resistin (RETN) in Indian and Pakistani cohorts and growth differentiation factor 5 (rs143383),, andin Thai populations are linked to OA risk. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For boswellia knee pain randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhang Yuntong (2025). Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis. DOI: 10.3390/nu17152547. PMCID: PMC12348802. PMID: 40806131. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12348802/
- Muacevic Alexander (2026). Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. DOI: 10.7759/cureus.109411. PMCID: PMC13283519. PMID: 42333321. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13283519/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.